NEJM Evidence (@nejmevidence) 's Twitter Profile
NEJM Evidence

@nejmevidence

NEJM Evidence, a new journal from NEJM Group, presents innovative #OriginalResearch and fresh, bold ideas in #ClinicalTrial design and clinical decision-making.

ID: 1423646013252907011

linkhttps://evidence.nejm.org/ calendar_today06-08-2021 14:04:23

2,2K Tweet

30,30K Followers

1,1K Following

NEJM (@nejm) 's Twitter Profile Photo

Our new partnership with Dr. Glaucomflecken has begun! Visit our new TikTok channel for his first video featuring Bug Bro and Ortho as they discuss whether iodine or chlorhexidine is better for surgical prep of an extremity fracture: tiktok.com/@nejm.org/vide…

NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

“Despite the strong evidence demonstrating the importance of sleep, many people fall short of sleep health targets.” 🛏 Learn more in a new review by Drs. Dr. Rebecca Robbins (PhD) and Stuart Quan: eviden.cc/4fc7hrm Harvard Medical School Division of Sleep Medicine #SleepMedicine

“Despite the strong evidence demonstrating the importance of sleep, many people fall short of sleep health targets.” 🛏 Learn more in a new review by Drs. <a href="/rebeccasrobbins/">Dr. Rebecca Robbins (PhD)</a> and Stuart Quan: eviden.cc/4fc7hrm 

<a href="/harvardsleepmed/">Harvard Medical School Division of Sleep Medicine</a> #SleepMedicine
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

Editorial: “Fenofibrate Shows Promise in Slowing Diabetic Retinopathy Progression” by Paolo S. Silva, MD, and Lloyd Paul Aiello, MD, PhD eviden.cc/4d8MqTP #Ophthalmology

Editorial: “Fenofibrate Shows Promise in Slowing Diabetic Retinopathy Progression” by Paolo S. Silva, MD, and Lloyd Paul Aiello, MD, PhD eviden.cc/4d8MqTP 

#Ophthalmology
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

For adults w/ heart failure & an ICD , can an SGLT2i ⬇️ a person’s risk of ventricular arrhythmias? Based on this double-blind RCT of ertugliflozin vs. placebo, it appears it can! 💓💊 eviden.cc/476qaIL Harald Sourij Martin Benedikt Daniel Scherr #ESCardio

For adults w/ heart failure &amp; an ICD , can an SGLT2i ⬇️ a person’s risk of ventricular arrhythmias? Based on this double-blind RCT of ertugliflozin vs. placebo, it appears it can! 💓💊 eviden.cc/476qaIL 

<a href="/HaraldSou/">Harald Sourij</a> <a href="/MartinBene1994/">Martin Benedikt</a> <a href="/DanielScherr3/">Daniel Scherr</a> #ESCardio
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

The incidence and geographic spread of Lyme disease is increasing in the United States. This Curbside Consult addresses common clinical considerations, including signs of early Lyme disease, testing, and treatment. Read the brief review: eviden.cc/3WbWTap

The incidence and geographic spread of Lyme disease is increasing in the United States. This Curbside Consult addresses common clinical considerations, including signs of early Lyme disease, testing, and treatment. Read the brief review: eviden.cc/3WbWTap
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

A group of readers share feedback about the data presented and the conclusions drawn in the recently published article by Glantz et al. ✉️ Read the remarks from these readers in the latest Exchange: eviden.cc/3zSmcH4 #MedicalResearch

A group of readers share feedback about the data presented and the conclusions drawn in the recently published article by Glantz et al. ✉️ Read the remarks from these readers in the latest Exchange: eviden.cc/3zSmcH4

#MedicalResearch
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

Read the Original Article by Stanton Glantz et al.: “Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes” eviden.cc/3PkdGph

Read the Original Article by <a href="/ProfGlantz/">Stanton Glantz</a> et al.: “Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes” eviden.cc/3PkdGph
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

Drs. Gwin and Davidson discuss a recent study on the use of the RSClin tool to predict the risk of late recurrence in patients with hormone receptor-positive, node negative breast cancer who have received 5 years of adjuvant endocrine therapy. 🔗 eviden.cc/4ff1YaM

Drs. Gwin and Davidson discuss a recent study on the use of the RSClin tool to predict the risk of late recurrence in patients with hormone receptor-positive, node negative breast cancer who have received 5 years of adjuvant endocrine therapy. 🔗 eviden.cc/4ff1YaM
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

A 53-year-old woman with a history of treated breast cancer has enlarged axillary lymph nodes. What is the differential diagnosis? 🩺 Read the Morning Report by a team from Hackensack Meridian School of Medicine: eviden.cc/3zSsHcQ Hackensack Meridian #MedTwitter

A 53-year-old woman with a history of treated breast cancer has enlarged axillary lymph nodes. What is the differential diagnosis? 🩺 Read the Morning Report by a team from <a href="/HMHSchoolofMed/">Hackensack Meridian School of Medicine</a>: eviden.cc/3zSsHcQ

<a href="/HMHNewJersey/">Hackensack Meridian</a> #MedTwitter
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

Editorial: “Intensive Glucose Control in Critically Ill Patients — How Low do We Go?” by Shohinee Sarma, MD, MPH, FRCPC eviden.cc/3WwnP5V #MedicalResearch #DiabetesCare

Editorial: “Intensive Glucose Control in Critically Ill Patients — How Low do We Go?” by Shohinee Sarma, MD, MPH, FRCPC eviden.cc/3WwnP5V

#MedicalResearch #DiabetesCare
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

Original Article: “Operative versus Nonoperative Treatment of Proximal Hamstring Avulsions” by Elsa Pihl, M.D., Ph.D., et al.: eviden.cc/4d87cTx Kenneth Jonsson Frede Frihagen #MedicalResearch #HamstringInjury #Orthopedics

Original Article: “Operative versus Nonoperative Treatment of Proximal Hamstring Avulsions” by Elsa Pihl, M.D., Ph.D., et al.: eviden.cc/4d87cTx

<a href="/kbjswe/">Kenneth Jonsson</a> <a href="/FredeFrihagen/">Frede Frihagen</a> #MedicalResearch #HamstringInjury #Orthopedics
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

Original Article: “Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival” by Joseph A. Sparano, MD, MD, et al.: eviden.cc/4de1EXF #Oncology #MedicalResearch

Original Article: “Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival” by <a href="/jsparano/">Joseph A. Sparano, MD</a>, MD, et al.: eviden.cc/4de1EXF 

#Oncology #MedicalResearch